95%
of hidden B2B decision-makers become more receptive to outreach after strong thought leadership.
Useful expertise can open doors that conventional sales collateral cannot.
Edelman × LinkedIn, 2025 ↗HOPLAB · LinkedIn evidence & commercial offer
Credibility first. Conversations next.
A research-grounded view of what LinkedIn can realistically produce for HOPLAB—and the 30-day offer we can responsibly sell to the client.
Research snapshot · July 2026
Executive conclusion
LinkedIn is a market-validation engine, not a lead vending machine.
For HOPLAB, the strongest model is founder-led credibility plus targeted outreach. Month one should validate the audience, proposition and sales conversation—not promise virality or guaranteed contracts.
What recent evidence says
Four findings shape the campaign.
2.60%
average engagement for personal profiles, versus 1.60% for company pages.
João and João Morais should drive distribution; the HOPLAB page should support credibility and amplification.
Metricool LinkedIn Study, 2026 ↗3×
benchmark engagement for LinkedIn healthcare campaigns featuring clinicians or experts.
Authentic scientific and clinical voices outperform generic healthcare promotion.
LinkedIn Healthcare Research, 2025 ↗26%
average connection acceptance; overall reply rates were approximately 7.2%.
Cold outreach works as a funnel, but targeting and relevance matter far more than clever automation.
Belkins Outreach Study, 2026 ↗Channel architecture
Three accounts. Three distinct jobs.
João Sá Gomes
Founder voice
The market problem, HOPLAB vision, customer stories, commercial insight and invitations to collaborate.
João Morais
Scientific voice
Physiology, wearable interpretation, testing principles, limitations of metrics and evidence-led guidance.
HOPLAB page
Trust infrastructure
Proof, programmes, product updates, event documentation, team amplification and a credible destination after discovery.
30-day forecast
A range—not a guarantee.
Planning model based on 10–15 carefully selected connection invitations per working day. Meeting estimates are HOPLAB planning scenarios, not published guarantees.
| Scenario | Invitations | Accepted connections | Genuine replies | Qualified meetings |
|---|---|---|---|---|
| Conservative | 200 | 40 | 2–3 | 0–1 |
| Realistic base | 250 | 60–70 | 5–8 | 1–2 |
| Strong execution | 300 | 90–105 | 10–13 | 2–4 |
The strong case requires precise targeting, credible profiles, consistent expert content, rapid personal responses, proper follow-up and a relevant CTA. A signed contract may happen, but should not be promised in month one: B2B journeys are commonly much longer. A LinkedIn/Dreamdata dataset reported a roughly 211-day average journey. Source ↗
Recommended client offer
HOPLAB LinkedIn Market Validation Sprint
We turn HOPLAB’s founder and scientific expertise into a credible LinkedIn presence, introduce it to 200–300 carefully selected decision-makers, generate qualified conversations, and establish which audience and proposition deserve further investment.
Positioning and optimisation of both João profiles
Separate founder and scientific narratives
8–16 substantial posts across both profiles
Carousels, visual explanations and expert video
200–300 hand-selected prospects
Human connection and follow-up sequences
Segment-specific landing pages and lead capture
Weekly funnel reporting and final decision report
Definition of success
We judge the system by movement through the funnel.
≥25%connection acceptance
≥8%reply rate after connecting
5–10meaningful conversations
1–3qualified meetings
1clearly stronger ICP/message
What we should not promise
- Viral reach or hundreds of leads.
- Three qualified meetings every week as a baseline.
- Closed contracts within the first month.
- That posting alone creates revenue.
- That AI automation can replace founder participation.
Fail-fast diagnostics
Every weak result should tell us what to fix.
Below 20% acceptance after 100 invitationsProfile credibility, ICP selection or connection context is wrong.
25%+ acceptance but below 5% repliesThe message or proposition is not relevant enough.
Replies but no meetingsThe CTA, commercial proposition or follow-up is weak.
Client execution below 80%The campaign cannot be fairly evaluated; founder participation is an operating dependency.